Top Markets
Coin of the day
Sofiva Genomics Co.,Ltd. Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.

6615
Xếp hạng trong cổ phiếu #29070
Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan,... Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan, offers a comprehensive range of genetic testing services to both domestic and international clients. The company's diverse diagnostic solutions are designed to support expectant parents, individuals with inherited conditions, and their families. Their extensive prenatal diagnostics include screenings for conditions such as thalassemia carrier status, various microdeletion syndromes, single-gene abnormalities, common chromosomal anomalies, and specific skeletal dysplasia mutations. They also provide multi-gene panel testing for inherited diseases, folate metabolism genetic analysis, carrier screening for spinal muscular atrophy (SMA) and Fragile X syndrome, congenital infection detection, preeclampsia risk assessment, maternal serum screening for Down syndrome, and karyotyping. Within the oncology sector, Sofiva Genomics delivers advanced cancer screenings, dynamic monitoring of tumor activity, and genetic evaluations for hereditary cancer predisposition. This includes specialized panels for women's cancers (breast, colon, ovarian, and endometrial), alongside human papillomavirus (HPV) screening. Furthermore, the company conducts genetic testing for rare diseases and provides specialized reproductive services such as preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS)-based preimplantation genetic screening (PGS). For newborns, their services encompass comprehensive "baby scans," screenings for hereditary sensorineural hearing loss, congenital central hypoventilation syndrome (CCHS), congenital cytomegalovirus (CMV) infection, and genetic risk assessment for atopic dermatitis. Beyond these specialized offerings, Sofiva Genomics also performs biochemical and chromosomal analyses, complemented by valuable advisory and support services for its clientele.
Giá cổ phiếu
$1.07
Vốn hóa thị trường
$23.11M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
4.66%
Quốc gia
TW
Giao dịch Sofiva Genomics Co.,Ltd. (6615)

Danh mục

EPS của Sofiva Genomics Co.,Ltd. (6615)
EPS tính đến 2026 TTM: 0
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Sofiva Genomics Co.,Ltd., EPS hiện tại của công ty (TTM) là 0. Vào cuối năm 2026, công ty có EPS là 0, bằng với EPS năm 2026 là 0.
Lịch sử EPS của Sofiva Genomics Co.,Ltd. từ 2026 đến 2026
EPS vào cuối mỗi năm
Năm EPS Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
Công ty EPS Chênh lệch EPS Quốc gia
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US